Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Clinical trial NCT05103358 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05103358
Sponsor: Aadi Bioscience, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Tumor Tumor, Solid Metastasis Metastatic Cancer Cancer Cancer Metastatic Tumors Neoplasms Neoplasm Metastasis Solid Tumor Advanced Solid Tumor Advanced Cancer

Start date: 2022-02-15
Primary completion: 2024-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.